The increasing number of individuals treated with drug-eluting stents can be
problematic perioperatively, especially when antiplatelet therapy must be
discontinued (eg, emergency spinal surgery). Such patients are at very increased
risk of thrombosis and perioperative MI. Anesthesia providers should never for
nonsurgical reasons (eg, desire to perform a spinal anesthetic) discontinue
antiplatelet or antithrombotic agents perioperatively without first discussing the
risks and benefits of the proposed anesthetic requiring suspension of antiplatelet
therapy with the patient and his or her cardiologist. The ACC/AHA guidelines
offer recommendations on the approach of bringing patients to surgery following
percutaneous coronary interventions and the type of interventions suggested
when subsequent surgery is expected (Figure 21-3).
Patient with coronary stent
FIGURE 21-3 Algorithm for antiplatelet management in patients with
percutaneous coronary intervention (PCI) and noncardiac surgery. Colors
correspond to the following classes of recommendations: class I, green; class IIa,
Scanned with CamScanner